IBDEI0ZD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16622,0)
 ;;=G10.^^67^769^20
 ;;^UTILITY(U,$J,358.3,16622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16622,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,16622,2)
 ;;=^5003751^F02.80
 ;;^UTILITY(U,$J,358.3,16623,0)
 ;;=G90.3^^67^769^21
 ;;^UTILITY(U,$J,358.3,16623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16623,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,16623,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,16624,0)
 ;;=G91.2^^67^769^22
 ;;^UTILITY(U,$J,358.3,16624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16624,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,16624,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,16625,0)
 ;;=G91.2^^67^769^23
 ;;^UTILITY(U,$J,358.3,16625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16625,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,16625,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,16626,0)
 ;;=G30.8^^67^769^5
 ;;^UTILITY(U,$J,358.3,16626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16626,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,16626,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,16626,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,16627,0)
 ;;=G31.09^^67^769^16
 ;;^UTILITY(U,$J,358.3,16627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16627,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,16627,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,16627,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,16628,0)
 ;;=G20.^^67^769^24
 ;;^UTILITY(U,$J,358.3,16628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16628,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,16628,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,16628,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,16629,0)
 ;;=G20.^^67^769^25
 ;;^UTILITY(U,$J,358.3,16629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16629,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,16629,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,16629,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,16630,0)
 ;;=G31.01^^67^769^26
 ;;^UTILITY(U,$J,358.3,16630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16630,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,16630,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,16630,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,16631,0)
 ;;=G23.1^^67^769^28
 ;;^UTILITY(U,$J,358.3,16631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16631,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,16631,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,16631,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,16632,0)
 ;;=99211^^68^770^1
 ;;^UTILITY(U,$J,358.3,16632,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16632,1,1,0)
 ;;=1^Brief Office Visit
 ;;^UTILITY(U,$J,358.3,16632,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,16633,0)
 ;;=99212^^68^770^2
 ;;^UTILITY(U,$J,358.3,16633,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16633,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,16633,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,16634,0)
 ;;=99213^^68^770^3
 ;;^UTILITY(U,$J,358.3,16634,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16634,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,16634,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,16635,0)
 ;;=99214^^68^770^4
 ;;^UTILITY(U,$J,358.3,16635,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16635,1,1,0)
 ;;=1^Detailed
